Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance.
- DOI
- 10.1016/j.cpt.2026.01.004
- Published
- 2026 Sep
- Container
- Cancer pathogenesis and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cpt.2026.01.004,
title = {Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance.},
author = {Ma W and Zhao H and Fan RR and Zhou C and Liu D and Chen S and Li T},
year = {2026},
journal = {Cancer pathogenesis and therapy},
doi = {10.1016/j.cpt.2026.01.004},
url = {https://doi.org/10.1016/j.cpt.2026.01.004}
}RIS
TY - JOUR TI - Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance. AU - Ma W AU - Zhao H AU - Fan RR AU - Zhou C AU - Liu D AU - Chen S AU - Li T PY - 2026 JO - Cancer pathogenesis and therapy DO - 10.1016/j.cpt.2026.01.004 UR - https://doi.org/10.1016/j.cpt.2026.01.004 ER -
APA
W, M., H, Z., RR, F., C, Z., D, L., S, C., & T, L. (2026). Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance.. Cancer pathogenesis and therapy. https://doi.org/10.1016/j.cpt.2026.01.004
Source records
- pubmed · retrieved 2026-09-26T22:05:59.371Z